Our data indicate that SF3B1 has a critical role in MDS by affecting the expression and splicing of genes involved in specific cellular processes/pathways, many of which are relevant to the known RARS pathophysiology, suggesting a causal link. This evidence concerns the gene SF3B1 and myelodysplastic syndrome with ring sideroblasts.